AnaptysBio Inc buy UBS Group AG
Start price
17.03.26
/
50%
€58.00
Target price
17.03.27
€78.28
Performance (%)
5.66%
Price
16.07.26
€47.68
Summary
This prediction is currently active. With a performance of 5.66%, the BUY prediction by UBS_Group_AG for AnaptysBio Inc is trending in the right direction. This prediction currently runs until 17.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -17.059% | -17.059% |
| iShares Core DAX® | -1,09 % | 0,20 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % |
| iShares S&P 500 | -0,20 % | 1,77 % |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its price target raised by UBS Group AG from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat